Timely and optimal treatment of patients with STEMI

@article{Lassen2013TimelyAO,
  title={Timely and optimal treatment of patients with STEMI},
  author={Jens F. Lassen and Hans Erik B{\o}tker and Christian Juhl Terkelsen},
  journal={Nature Reviews Cardiology},
  year={2013},
  volume={10},
  pages={41-48}
}
Fibrinolysis is recommended in European and US guidelines for patients with ST-segment elevation myocardial infarction (STEMI) when a strategy of primary percutaneous coronary intervention (PPCI) is associated with ≥120 min delay from first medical contact (FMC), defined as call to the emergency medical services or self-presentation at hospital. Current evidence indicates that reperfusion therapy should be initiated as soon as possible after FMC. However, fibrinolysis cannot be initiated… 
Multicentre analysis of current ST-elevation myocardial infarction acute care pathways
TLDR
Insight was gained into how Dutch PCI centres try to achieve time targets by comparing their care processes with one another and with the European guideline-recommended process, and numerous differences in processes between PCI centres were identified.
Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment–Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment–Elevation Myocardial Infarction)
TLDR
For patients with STEMI presenting ⩽6 hours after symptom onset and with an expected PCI-related delay, a PhI strategy with half-dose alteplase and timely PCI offers more complete epicardial and myocardial reperfusion when compared with PPCI.
Thrombus aspiration in elderly STEMI patients: a single center experience.
Effect of introducing a regional 24/7 primary percutaneous coronary intervention service network on treatment outcomes in patients with ST segment elevation myocardial infarction.
TLDR
Introduction of a 24/7 primary PCI regional service (STEMI network) led to improved accessibility of invasive diagnosis and treatment and increased reperfusion treatment rates, resulting in reduced in-hospital and 1-year mortality among STEMI patients.
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.
TLDR
Large variations in reperfusion treatment are still present across Europe, and countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusions therapy.
Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction
TLDR
RIC as adjunctive to pPCI attenuated the detrimental effect of healthcare system delay on myocardial salvage in patients with STEMI, suggesting that the cardioprotective effect of RIC increases with the duration of ischaemia.
Improving outcomes in patients with coronary heart disease using national registers and platelet function testing
TLDR
It is shown that a register based randomized clinical trial designed to evaluate bivalirudin versus heparin in patients with ACS and PCI is feasible, with a higher degree of enrollment of “real-life” patients than in conventional randomized clinical trials.
IN-HOSPITAL MORTALITY IN ELDERLY (>75 YEARS) PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH ACUTE ST ELEVATION MYOCARDIAL INFARCTION AT AFIC-NIHD RAWALPINDI
TLDR
Primary PCI for elderly patients presenting with acute ST segment elevation myocardial infarction is a safe and effective mode of revascularization with high success rate and low mortality.
...
...

References

SHOWING 1-10 OF 82 REFERENCES
Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time
TLDR
The evidence supports an acceptable PCI-related delay of 80–120 min and PPCI as the better reperfusion strategy also in the early incomers and the previous assumption that PPCi is less time-dependent than fibrinolysis is questioned.
System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention.
TLDR
System delay was associated with mortality in patients with STEMI treated with primary PCI, as was its components, prehospital system delay and door-to-balloon delay.
Routine early angioplasty after fibrinolysis for acute myocardial infarction.
TLDR
Among high-risk patients who had a myocardial infarction with ST-segment elevation and who were treated with fibrinolysis, transfer for PCI within 6 hours after fibrinelysis was associated with significantly fewer ischemic complications than was standard treatment.
Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy
TLDR
As DB-DN times increase, the mortality advantage of PPCI over fibrinolysis declines, and this advantage varies considerably depending on patient characteristics.
Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction.
TLDR
Thrombolytic therapy is still the fastest and best accessible reperfusion treatment for most patients presenting with acute STEMI, as indicated in the international guidelines, and PPCI is only available on an average for 15–20% of patients suffering from STEMI in the western world.
Facilitated percutaneous coronary intervention: current concepts, promises, and pitfalls.
TLDR
The evidence to date suggests that fibrinolytic-facilitated PCI is associated with higher mortality rates and adverse events compared with primary PCI and facilitated PCI utilizing a glycoprotein IIbIIIa inhibitor agent has no considerable benefit on mortality in STEMI in contemporary practice.
Primary Percutaneous Coronary Intervention as a National Reperfusion Strategy in Patients With ST-Segment Elevation Myocardial Infarction
TLDR
A reperfusion strategy with PPCI only for patients with ST-segment elevation myocardial infarction was successfully implemented in Western Denmark, and the majority of patients transported by the EMS are now triaged directly to the P PCI centers, which is associated with lower mortality.
Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?
TLDR
In patients presenting 2 to 3 hours after onset of symptoms, a strategy of facilitated PCI may move patients from the plateau to the descending limb of the curve, with a substantial improvement in myocardial salvage and mortality.
Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase
TLDR
PCI-related delays are extensive among patients transferred for X-PCI and are associated with poorer outcomes, but as XDB door-to-needle time times increase, the mortality advantage for X -PCI over O-FT declines.
...
...